ArticleCancers2023

Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.

Nikolai Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.